Welcome to the IMPULSE initiative
As Europe’s leading platform for chemical biology and early drug discovery, EU-OPENSCREEN ERIC strives to offer the most advanced scientific services in these fields to researchers across academia and industry.
Under the EU-funded initiative IMPULSE, a consortium of EU-OPENSCREEN partners is working to ensure that EU-OPENSCREEN remains at the forefront of the field and addresses the ever-growing needs of the scientific community in Europe and beyond.
Full name: IMPROVING USER EXPERIENCE, LONG-TERM SUSTAINABILITY, AND SERVICES OF EU-OPENSCREEN
Funding programme: Horizon Europe
Grant agreement number: 101132028
Budget: €5M (€4M funded by the EU Commission)
Coordinator: EU-OPENSCREEN ERIC
Duration: March 1, 2024 – February 28, 2027
IMPULSE seeks to enhance EU-OPENSCREEN's role as a premier platform for chemical biology and early drug discovery in Europe
The project focusses on four key areas:
Enhancing the Service Catalogue:
Integrating AI/ML, advanced disease models, genetic approaches and novel chemical targeting methods into our service catalogue to develop potent compounds for research and applications in the pharmaceutical and agrochemical sectors.
Improving Standards:
Implementing operational and data standards across our partner site network to enhance data reproducibility and accessibility, complemented by staff training and user feedback for optimal service delivery.
Community Engagement:
Promoting new services to attract researchers in academia and industry, expanding our research infrastructure's relevance and trustworthiness through harmonised standards and valuable datasets generated using advanced technologies.
Ensuring Sustainability
Enlarging the funding base of EU-OPENSCREEN by engaging additional ERIC member countries, fostering partnerships across research infrastructures and with stakeholders, and developing innovative funding models for sustainable drug discovery.
This project has received funding from the European Union’s Horizon Europe research and innovation programme under the Grant Agreement No. 101132028.